Atibuclimab is named as an intervention in 2 current clinical trials in our USA register. 1 is recruiting patients now. The most common phase is Phase 1/2. The lead sponsor is Implicit Bioscience. The most-studied condition is Acute Decompensated Heart Failure.
| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Anti-CD14 Treatment With IC14 in Hospitalized ARDS Patients
NCT06513949 · ClinicalTrials.gov ↗ · Acute Respiratory Distress Syndrome, Adult Respiratory Distress Syndrome, Acute Lung Injury
|
Phase 2 | Recruiting | Implicit Bioscience | USA |
|
IC14 for Treatment of Acute Decompensated Heart Failure
NCT06556810 · ClinicalTrials.gov ↗ · Acute Decompensated Heart Failure
|
Phase 1/2 | Active, closed | Implicit Bioscience | USA |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Lead sponsor | Trials |
|---|---|
| Implicit Bioscience | 2 |
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in USA | 2 | 1 |
A trial with sites in more than one country appears in each of those registers.
2 current trials in our USA register name Atibuclimab (also registered as IC14) as a drug or biological intervention, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Yes. 1 of the 2 trials is recruiting: 1 with sites in USA. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
The lead sponsor is Implicit Bioscience. The number in brackets is how many trials each organisation leads.
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Atibuclimab works or whether it is effective, and it is not medical advice.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Atibuclimab works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Atibuclimab (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 26 Sep 2026.